Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

Choosing antithrombotic regimens for patients with atrial fibrillation (AF) who underwent percutaneous coronary intervention (PCI) with stent placement is challenging. Until recently, the guidelines recommended warfarin-based triple therapy, which causes frequent major bleeding events in up to 12% o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Soongu, Yang, Han-Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379079/
https://www.ncbi.nlm.nih.gov/pubmed/32821695
http://dx.doi.org/10.12997/jla.2019.8.1.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379079/
https://www.ncbi.nlm.nih.gov/pubmed/32821695
http://dx.doi.org/10.12997/jla.2019.8.1.8

Ejemplares similares